Hui Hao Lu
Director/Board Member chez ZHEJIANG ANGLIKANG PHARMACEUTICAL CO.,LTD.
Fortune : 16 M $ au 31/03/2024
Profil
Hui Hao Lu has worked as a Director and Deputy General Manager at Zhejiang Anglikang Pharmaceutical Co. Ltd.
since 2014.
He is also currently a Director at Hunan Kerey Pharmaceutical Co., Ltd.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 30/09/2022 | 5 440 219 ( 33,07% ) | 12 M $ | 31/03/2024 | |
| 30/09/2022 | 1 813 406 ( 0,98% ) | 4 M $ | 31/03/2024 |
Postes actifs de Hui Hao Lu
| Sociétés | Poste | Début |
|---|---|---|
| ZHEJIANG ANGLIKANG PHARMACEUTICAL CO.,LTD. | Director/Board Member | 09/12/2014 |
Hunan Kerey Pharmaceutical Co., Ltd.
 Hunan Kerey Pharmaceutical Co., Ltd. Pharmaceuticals: MajorHealth Technology Hunan Kerey Pharmaceutical Co., Ltd. engages in the research, development, production, and sale of pharmaceutical intermediates. Its products include special active pharmaceutical ingredients, plant-origin cholesterol and vitamin D, plant-origin cholic acids, brassinolides, and key intermediates. The company was founded in 2005 and is headquartered in Shaoyang, China. | Director/Board Member | - |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 2 |
|---|---|
| ZHEJIANG ANGLIKANG PHARMACEUTICAL CO.,LTD. | Health Technology |
 | Health Technology |
